Literature DB >> 22706959

Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal.

Omar Ly1, Papa ElHadji Omar Gueye, Awa Bineta Deme, Therese Dieng, Aida Sadikh Badiane, Ambroise D Ahouidi, Mouhamadou Diallo, Amy K Bei, Dyann F Wirth, Souleymane Mboup, Ousmane Sarr.   

Abstract

The goal of the present study was to assess the evolution of the in vitro chloroquine resistance and also the prevalence of pfcrt T76 and pfmdr1 Y86 mutations in Pikine from 2000 while chloroquine (CQ) was the first-line treatment of malaria to 2009 when artemisinin-based combination therapies (ACTs) are in use. We genotyped pfcrt K76T and pfmdr1 N86Y polymorphisms by PCR-RFLP and assessed in vitro CQ susceptibility by double-site enzyme-linked pLDH immunodetection (DELI) assay in Plasmodium falciparum isolates collected in Pikine, Senegal. The proportions of the pfcrt T76 allele in the light of the three different treatment policies were 72.4 % before CQ withdrawal (2000 to 2003), 47.2% while amodiaquine plus Fansidar was the first-line treatment (2004 to 2005), and 59.5 % since the ACT use was implemented (2006 to 2009). The prevalence of pfcrt T76 decreased significantly after CQ was stopped [X (2) = 6.54, P = 0.01 (2000-2003 versus 2004-2005)] and then slightly since ACTs have been implemented [X(2) = 1.12, P = 0.28 (2000-2003 versus 2006-2009)]. There were no significant differences on the prevalence of pfmdr1 Y86 throughout the three treatment policies. The DELI assay was carried out episodically in 2000 (n = 36), 2001 (n = 47), and 2009 (n = 37). The mean IC(50)s of the isolates to CQ in 2000 versus 2009 and 2001 versus 2009 are significantly different (P < 0.05). The Fisher exact test found a significant association between the presence of the pfcrt T76 mutant allele and in vitro resistance in 2000/2001 (P = 0.023), while in 2009 there were no association between both variables (P = 0.274). Mutant pfcrt T76 and pfmdr1 Y86 alleles and in vitro CQ-resistant strains are still circulating in Pikine. The official discontinuation of CQ use is not completely followed by its total withdrawal from private drug sellers, and the molecule still exerts pressure on local P. falciparum populations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22706959     DOI: 10.1007/s00436-012-2994-7

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  41 in total

1.  Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum.

Authors:  M B Reed; K J Saliba; S R Caruana; K Kirk; A F Cowman
Journal:  Nature       Date:  2000-02-24       Impact factor: 49.962

2.  Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance.

Authors:  D A Fidock; T Nomura; A K Talley; R A Cooper; S M Dzekunov; M T Ferdig; L M Ursos; A B Sidhu; B Naudé; K W Deitsch; X Z Su; J C Wootton; P D Roepe; T E Wellems
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

3.  In vivo and in vitro analysis of chloroquine resistance in Plasmodium falciparum isolates from Senegal.

Authors:  Ousmane Sarr; Alissa Myrick; Johanna Daily; Bernard M Diop; Therese Dieng; Omar Ndir; Pape Salif Sow; Souleymane Mboup; Dyann F Wirth
Journal:  Parasitol Res       Date:  2005-06-29       Impact factor: 2.289

4.  Evaluation under field conditions of the colourimetric DELI-microtest for the assessment of Plasmodium falciparum drug resistance.

Authors:  A Moreno; P Brasseur; N Cuzin-Ouattara; C Blanc; P Druilhe
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.184

5.  In vitro chloroquine susceptibility and PCR analysis of pfcrt and pfmdr1 polymorphisms in Plasmodium falciparum isolates from Senegal.

Authors:  Susan M Thomas; Omar Ndir; Therese Dieng; Souleymane Mboup; David Wypij; James H Maguire; Dyann F Wirth
Journal:  Am J Trop Med Hyg       Date:  2002-05       Impact factor: 2.345

6.  Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa.

Authors:  Gabrielle Holmgren; Johan Hamrin; Jenny Svärd; Andreas Mårtensson; José Pedro Gil; Anders Björkman
Journal:  Infect Genet Evol       Date:  2007-03-31       Impact factor: 3.342

7.  Artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Arjen M Dondorp; François Nosten; Poravuth Yi; Debashish Das; Aung Phae Phyo; Joel Tarning; Khin Maung Lwin; Frederic Ariey; Warunee Hanpithakpong; Sue J Lee; Pascal Ringwald; Kamolrat Silamut; Mallika Imwong; Kesinee Chotivanich; Pharath Lim; Trent Herdman; Sen Sam An; Shunmay Yeung; Pratap Singhasivanon; Nicholas P J Day; Niklas Lindegardh; Duong Socheat; Nicholas J White
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

Review 8.  Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations.

Authors:  Mark A Travassos; Miriam K Laufer
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

9.  Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.

Authors:  Alisa P Alker; Pharath Lim; Rithy Sem; Naman K Shah; Poravuth Yi; Denis Mey Bouth; Reiko Tsuyuoka; Jason D Maguire; Thierry Fandeur; Frederic Ariey; Chansuda Wongsrichanalai; Steven R Meshnick
Journal:  Am J Trop Med Hyg       Date:  2007-04       Impact factor: 2.345

10.  Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.

Authors:  Babacar Faye; Jean-Louis Ndiaye; Daouda Ndiaye; Yemou Dieng; Oumar Faye; Oumar Gaye
Journal:  Malar J       Date:  2007-06-14       Impact factor: 2.979

View more
  15 in total

Review 1.  PfCRT and its role in antimalarial drug resistance.

Authors:  Andrea Ecker; Adele M Lehane; Jérôme Clain; David A Fidock
Journal:  Trends Parasitol       Date:  2012-09-25

2.  Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya.

Authors:  John Okombo; Alice W Kamau; Kevin Marsh; Colin J Sutherland; Lynette Isabella Ochola-Oyier
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-08-07       Impact factor: 4.077

3.  Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013-2014 malaria season.

Authors:  Bécaye Fall; Cheikhou Camara; Mansour Fall; Aminata Nakoulima; Pierre Dionne; Bakary Diatta; Yaya Diemé; Boubacar Wade; Bruno Pradines
Journal:  Malar J       Date:  2015-02-06       Impact factor: 2.979

4.  Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014.

Authors:  Bécaye Fall; Marylin Madamet; Cheikhou Camara; Rémy Amalvict; Mansour Fall; Aminata Nakoulima; Bakary Diatta; Yaya Diémé; Boubacar Wade; Bruno Pradines
Journal:  Emerg Infect Dis       Date:  2016-05       Impact factor: 6.883

5.  West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia.

Authors:  Baba Dieye; Muna Affara; Lassana Sangare; Fatou Joof; Yaye D Ndiaye; Jules F Gomis; Mouhamadou Ndiaye; Aminata Mbaye; Mouhamadou Diakite; Ngayo Sy; Babacar Mbengue; Awa B Deme; Rachel Daniels; Ambroise D Ahouidi; Tandakha Dieye; Ahmad Abdullahi; Seydou Doumbia; Jean L Ndiaye; Ayouba Diarra; Abubakar Ismaela; Mamadou Coulibaly; Clint Welty; Alfred Amambua Ngwa; Jeffrey Shaffer; Umberto D'Alessandro; Sarah K Volkman; Dyann F Wirth; Donald J Krogstad; Ousmane Koita; Davis Nwakanma; Daouda Ndiaye
Journal:  Am J Trop Med Hyg       Date:  2016-08-22       Impact factor: 2.345

6.  Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.

Authors:  Bécaye Fall; Aurélie Pascual; Fatoumata D Sarr; Nathalie Wurtz; Vincent Richard; Eric Baret; Yaya Diémé; Sébastien Briolant; Raymond Bercion; Boubacar Wade; Adama Tall; Bruno Pradines
Journal:  Malar J       Date:  2013-03-20       Impact factor: 2.979

7.  Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011.

Authors:  Myriam Gharbi; Jennifer A Flegg; Véronique Hubert; Eric Kendjo; Jessica E Metcalf; Lionel Bertaux; Philippe J Guérin; Jacques Le Bras; Ahmed Aboubaca; Patrice Agnamey; Adela Angoulvant; Patricia Barbut; Didier Basset; Ghania Belkadi; Anne Pauline Bellanger; Dieudonné Bemba; Françoise Benoit-Vica; Antoine Berry; Marie-Laure Bigel; Julie Bonhomme; Françoise Botterel; Olivier Bouchaud; Marie-Elisabeth Bougnoux; Patrice Bourée; Nathalie Bourgeois; Catherine Branger; Laurent Bret; Bernadette Buret; Enrique Casalino; Sylviane Chevrier; Frédérique Conquere de Monbrison; Bernadette Cuisenier; Martin Danis; Marie-Laure Darde; Ludovic De Gentile; Jean-Marie Delarbre; Pascal Delaunay; Anne Delaval; Guillaume Desoubeaux; Michel Develoux; Jean Dunand; Rémy Durand; Odile Eloy; Nathalie Fauchet; Bernard Faugere; Alber Faye; Odile Fenneteau; Pierre Flori; Madeleine Fontrouge; Chantal Garabedian; Françoise Gayandrieu; Nadine Godineau; Pascal Houzé; Sandrine Houzé; Jean-Pierre Hurst; Houria Ichou; Laurence Lachaud; Agathe Lebuisson; Magalie Lefevre; Anne-Sophie LeGuern; Gwenaë Le Moal; Daniel Lusina; Marie-Claude Machouart; Denis Malvy; Sophie Matheron; Danièle Maubon; Denis Mechali; Bruno Megarbane; Guillaume Menard; Laurence Millon; Muriel Mimoun Aiach; Philippe Minodier; Christelle Morelle; Gilles Nevez; Philippe Parola; Daniel Parzy; Olivier Patey; Pierre Patoz; Pascale Penn; Alice Perignon; Stéphane Picot; Jean-Etienne Pilo; Isabelle Poilane; Denis Pons; Marie Poupart; Bruno Pradines; Didier Raffenot; Christophe Rapp; Marie-Catherine Receveur; Claudine Sarfati; Yaye Senghor; Fabrice Simon; Jean-Yves Siriez; Nicolas Taudon; Marc Thellier; Maxime Thouvenin; Dominique Toubas
Journal:  Malar J       Date:  2013-01-25       Impact factor: 2.979

8.  Use of proscribed chloroquine is associated with an increased risk of pfcrt T76 mutation in some parts of Ghana.

Authors:  Kwame K Asare; Johnson N Boampong; Richmond Afoakwah; Elvis O Ameyaw; Rakesh Sehgal; Neils B Quashie
Journal:  Malar J       Date:  2014-06-26       Impact factor: 2.979

9.  Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014.

Authors:  Agathe Boussaroque; Bécaye Fall; Marylin Madamet; Khalifa Ababacar Wade; Mansour Fall; Aminata Nakoulima; Khadidiatou Ba Fall; Pierre Dionne; Nicolas Benoit; Bakary Diatta; Yaya Diemé; Boubacar Wade; Bruno Pradines
Journal:  Malar J       Date:  2016-07-07       Impact factor: 2.979

10.  Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.

Authors:  Aminata Mbaye; Baba Dieye; Yaye D Ndiaye; Amy K Bei; Affara Muna; Awa B Deme; Mamadou S Yade; Khadim Diongue; Amy Gaye; Ibrahima M Ndiaye; Tolla Ndiaye; Mouhamad Sy; Mamadou A Diallo; Aida S Badiane; Mouhamadou Ndiaye; Mame C Seck; Ngayo Sy; Ousmane Koita; Donald J Krogstad; Davis Nwakanma; Daouda Ndiaye
Journal:  Malar J       Date:  2016-08-25       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.